Primary pulmonary hypertension.
Haworth
S G
SG
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001067:Appetite Depressants / Q000009:adverse effects; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D011464:Epoprostenol / Q000627:therapeutic use; D005260:Female; D005277:Fenfluramine / Q000009:adverse effects; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000628:therapy; D016040:Lung Transplantation; D015337:Multicenter Studies as Topic; D010102:Oxygen Inhalation Therapy; D014665:Vasodilator Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001067:Appetite Depressants; D002121:Calcium Channel Blockers; D014665:Vasodilator Agents; D005277:Fenfluramine; D011464:Epoprostenol